Fiera Capital (Canada)
XENE icon

Fiera Capital (Canada)’s Xenon Pharmaceuticals XENE Stock Holding History

Fiera Capital (Canada)’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.3M Buy
411,032
+5,394
+1% +$320K 0.06% 195
2026
Q2 		$24.5M Sell
405,638
-303,891
-43% -$16.9M 0.09% 156
2026
Q1 		$41.3M Buy
709,529
+23,473
+3% +$1.08M 0.14% 129
2025
Q4 		$30.7M Buy
686,056
+166,057
+32% +$6.97M 0.1% 156
2025
Q3 		$20.9M Sell
519,999
-10,684
-2% -$376K 0.07% 162
2025
Q2 		$16.6M Buy
530,683
+1,241
+0.2% +$40.5K 0.06% 164
2025
Q1 		$17.8M Sell
529,442
-6,445
-1% -$245K 0.06% 162
2024
Q4 		$21M Sell
535,887
-18,313
-3% -$757K 0.07% 147
2024
Q3 		$21.8M Sell
554,200
-28,679
-5% -$1.16M 0.07% 150
2024
Q2 		$22.7M Buy
582,879
+6,337
+1% +$253K 0.07% 141
2024
Q1 		$24.8M Buy
576,542
+23,512
+4% +$1.08M 0.07% 140
2023
Q4 		$25.5M Sell
553,030
-7,516
-1% -$266K 0.08% 137
2023
Q3 		$19.1M Buy
560,546
+11,205
+2% +$419K 0.06% 151
2023
Q2 		$21.1M Buy
+549,341
New +$21.8M 0.06% 144

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Fiera Capital (Canada)'s XENE Position: Q3 2026 in Review

Fiera Capital (Canada) increased its Xenon Pharmaceuticals (XENE) stake by 1.3% in Q3 2026, buying an estimated $320K and bringing the position to 411,032 shares worth $15.3M. The position accounts for 0.06% of the portfolio, ranked #195.

Fiera Capital (Canada) first reported a position in XENE in Q2 2023 and has held it in 14 quarters since. The position peaked at $41.3M in Q1 2026. 156 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • Fiera Capital (Canada) held 411,032 shares of Xenon Pharmaceuticals worth $15.3M as of Q3 2026.
  • Fiera Capital (Canada) bought 5,394 Xenon Pharmaceuticals shares in Q3 2026, an estimated $320K.
  • Xenon Pharmaceuticals made up 0.06% of Fiera Capital (Canada)'s portfolio in Q3 2026, its #195 holding.
  • Fiera Capital (Canada) first reported a position in Xenon Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
  • Fiera Capital (Canada)'s Xenon Pharmaceuticals position peaked at $41.3M in Q1 2026.
  • 156 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2026, filed 6 Nov 2026.